Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 4.81
- Piotroski Score 8.00
- Grade Outperform
- Symbol (COR)
- Company Cencora
- Price $244.97
- Changes Percentage (-0.29%)
- Change -$0.72
- Day Low $244.67
- Day High $247.55
- Year High $251.56
Cencora, Inc. sources and distributes pharmaceutical products. Its U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The company also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; and pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. The company's International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; and distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers and hospitals primarily in Europe. This segment also provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.
- Last Earnings 11/05/2024
- Ex-Dividend for 5/16 Dividend 11/15/2024
- Dividend Payable 11/29/2024
- Today N/A
- Next Earnings (Estimated) 01/29/2025
- Fiscal Year End N/A
- Average Stock Price Target $175.50
- High Stock Price Target $284.00
- Low Stock Price Target $150.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $9.14
- Trailing P/E Ratio 25.76
- Forward P/E Ratio 25.76
- P/E Growth 25.76
- Net Income $1.51 B
Income Statement
Quarterly
Annual
Latest News of COR
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
F1 Las Vegas GP preview: Mercedes eyes surprise win as Verstappen nears coronation
George Russell clinched pole position for the Las Vegas Grand Prix, surprising many with his impressive pace. Ferrari's Carlos Sainz and Pierre Gasly secured second and third, respectively. Verstappen...
By The New York Times | 21 hours ago -
A Long-Held Secret is Now Public. Will it Alter Cormac McCarthy's Legacy?
Vanity Fair's article revealed Cormac McCarthy's relationship with a girl he met at 16, sparking debate on her influence on his writing. Scholars remain skeptical of claims linking her to characters i...
By The New York Times | 21 hours ago -
Ukraine scores major NASAMS air defense boost from NATO
Ukraine received a NASAMS surface-to-air missile system from Canada to boost air defense capabilities against drone, missile, and aircraft attacks. This donation is part of $500 million military aid p...
By Newsweek | 22 hours ago
